年度	2019
全部作者	陈秉训
论文名称	Ping-Hsun Chen*, 2019.05, 'A Brand-Name Drug Company May Violate Section Two of the Sherman Act by Mislabeling a Submitted Patent in the Orange Book: An Implication from In Re Actos End-Payor Antitrust Litigation, 848 F.3d 89 (2d Cir. 2017), ' Brooklyn Journal of Corporate, Financial & Commercial Law, Vol.13, No.2, pp.395-416.(Westlaw)(*为通讯作者)
卷数	422608
发表日期	2019-05-01